HER2-positive breast cancer is a breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2), which promotes the.
HER2 (human epidermal growth factor receptor 2) is a gene that can play a role in the development of breast cancer. Breast cancers with HER2 gene amplification or HER2 protein overexpression are called HER2-positive in the pathology report. The results of the IHC test can be: 0.
Keywords: breast cancer, drug–antibody conjugates, HER2-positive, new HER2 and HER3 mRNA levels were associated with a significantly.